Hadi, Sutopo and Suhartati, Tati and Qudus, Hardoko Insan and Yandri, Yandri (2019) The Biological Activity of Some Organotin(IV) benzoate compounds as new antimalarial agents. In: SEMIRATA-International Conference on Science and Technology (ICST) 2019 Bengkulu, 5-7 July 2019, Bengkulu. (Unpublished)
|
Text
Abstract-Sutopo Hadi_2019_semirata.pdf Download (9kB) | Preview |
Abstract
The organotin(IV) carboxylate and its derivatives are widely known since the derivative of these compounds are very active and strong even at very low concentration. This condition makes these compounds continue to attract more attention to be used in many biological activities. We have previously succeeded in the syntheses and performed many activity studies of some organotin(IV) benzoates, in this work, we reported the antimalarial activity studies of some organotin(IV) derivatives. The targeted compounds were prepared from their organotin(IV) chlorides via the intermediate products of dibutyltin(IV) oxide, diphenyltin(IV) dihydroxide and triphenyltin(IV) hydroxide, respectively and followed by reacting the intermediate products with 2,3,4-chlorobenzoic acid. The antimalaria activity was performed against Plasmodium falcifarum. The results showed that the IC50 of all organotin(IV) compounds tested were little bit higher than the chloroquine as the positive control, however one advantage is that the organotin(IV) compounds are not resistent to the Plasmodium, thus making the used of organotin(IV) as antimalaria is widely opened. The triphenyltin(IV) compound is more potent to be used as antimalaria and has potential to be developed as antimalarial drug in the near future.
Item Type: | Conference or Workshop Item (Paper) |
---|---|
Subjects: | Q Science > QD Chemistry |
Divisions: | Fakultas Matematika dan Ilmu Pengetahuan Alam (FMIPA) > Prodi Kimia |
Depositing User: | Prof. Sutopo Hadi |
Date Deposited: | 02 Jun 2020 07:16 |
Last Modified: | 02 Jun 2020 07:16 |
URI: | http://repository.lppm.unila.ac.id/id/eprint/21478 |
Actions (login required)
View Item |